Literature DB >> 19631267

Inflammation induces fibrinogen nitration in experimental human endotoxemia.

Sean P Heffron1, Ioannis Parastatidis, Marina Cuchel, Megan L Wolfe, Mahlet G Tadesse, Emille R Mohler, Harry Ischiropoulos, Daniel J Rader, Muredach P Reilly.   

Abstract

Elevated plasma fibrinogen is a prothrombotic risk factor for cardiovascular disease (CVD). Recent small studies report that fibrinogen oxidative modifications, specifically tyrosine residue nitration, can occur in inflammatory states and may modify fibrinogen function. HDL cholesterol is inversely related to CVD and suggested to reduce the oxidation of LDL cholesterol, but whether these antioxidant functions extend to fibrinogen modifications is unknown. We used a recently validated ELISA to quantify nitrated fibrinogen during experimental human endotoxemia (N=23) and in a cohort of healthy adults (N=361) who were characterized for inflammatory and HDL parameters as well as subclinical atherosclerosis measures, carotid artery intima-medial thickness (IMT) and coronary artery calcification (CAC). Fibrinogen nitration increased following endotoxemia and directly correlated with accelerated ex vivo plasma clotting velocity. In the observational cohort, nitrated fibrinogen was associated with levels of CRP and serum amyloid A. Nitrated fibrinogen levels were not lower with increasing HDL cholesterol and did not associate with IMT and CAC. In humans, fibrinogen nitration was induced during inflammation and was correlated with markers of inflammation and clotting function but not HDL cholesterol or subclinical atherosclerosis in our modest sample. Inflammation-induced fibrinogen nitration may be a risk factor for promoting CVD events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631267      PMCID: PMC3651370          DOI: 10.1016/j.freeradbiomed.2009.07.025

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  32 in total

1.  Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy.

Authors:  Mehdi H Shishehbor; Ronnier J Aviles; Marie-Luise Brennan; Xiaoming Fu; Marlene Goormastic; Gregory L Pearce; Noyan Gokce; John F Keaney; Marc S Penn; Dennis L Sprecher; Joseph A Vita; Stanley L Hazen
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

2.  Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans.

Authors:  Johannes Pleiner; Elisabeth Heere-Ress; Herbert Langenberger; Anna E Sieder; Michaela Bayerle-Eder; Fritz Mittermayer; Gabriele Fuchsjäger-Mayrl; Johannes Böhm; Burkhard Jansen; Michael Wolzt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-01       Impact factor: 8.311

3.  Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome.

Authors:  M D Gole; J M Souza; I Choi; C Hertkorn; S Malcolm; R F Foust; B Finkel; P N Lanken; H Ischiropoulos
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-05       Impact factor: 5.464

4.  Nitrated and oxidized plasma proteins in smokers and lung cancer patients.

Authors:  B Pignatelli; C Q Li; P Boffetta; Q Chen; W Ahrens; F Nyberg; A Mukeria; I Bruske-Hohlfeld; C Fortes; V Constantinescu; H Ischiropoulos; H Ohshima
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

5.  Myeloperoxidase produces nitrating oxidants in vivo.

Authors:  Joseph P Gaut; Jaeman Byun; Hung D Tran; Wendy M Lauber; James A Carroll; Richard S Hotchkiss; Abderrazzaq Belaaouaj; Jay W Heinecke
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

6.  A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species.

Authors:  Marie-Luise Brennan; Weijia Wu; Xiaoming Fu; Zhongzhu Shen; Wei Song; Heather Frost; Caryn Vadseth; Laura Narine; Elizabeth Lenkiewicz; Michael T Borchers; Aldons J Lusis; James J Lee; Nancy A Lee; Husam M Abu-Soud; Harry Ischiropoulos; Stanley L Hazen
Journal:  J Biol Chem       Date:  2002-02-27       Impact factor: 5.157

7.  Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults.

Authors:  George T Kondos; Julie Anne Hoff; Alexander Sevrukov; Martha L Daviglus; Daniel B Garside; Stephen S Devries; Eva V Chomka; Kiang Liu
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

8.  Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice.

Authors:  Ioannis Parastatidis; Leonor Thomson; Diana M Fries; Ryan E Moore; Junichiro Tohyama; Xiaoming Fu; Stanley L Hazen; Harry F G Heijnen; Michelle K Dennehy; Daniel C Liebler; Daniel J Rader; Harry Ischiropoulos
Journal:  Circ Res       Date:  2007-07-05       Impact factor: 17.367

Review 9.  Regulation of reverse cholesterol transport and clinical implications.

Authors:  Daniel J Rader
Journal:  Am J Cardiol       Date:  2003-08-18       Impact factor: 2.778

Review 10.  Reactive nitrogen species in the chemical biology of inflammation.

Authors:  Peter C Dedon; Steven R Tannenbaum
Journal:  Arch Biochem Biophys       Date:  2004-03-01       Impact factor: 4.013

View more
  11 in total

1.  Absence of inflammatory conditions in human varicose saphenous veins.

Authors:  Ingrid Gomez; Chabha Benyahia; Julien Le Dall; Christine Payré; Liliane Louedec; Guy Leséche; Gérard Lambeau; Dan Longrois; Xavier Norel
Journal:  Inflamm Res       Date:  2012-12-13       Impact factor: 4.575

Review 2.  Fibrin Formation, Structure and Properties.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Subcell Biochem       Date:  2017

Review 3.  Functional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots.

Authors:  Marissa Martinez; John W Weisel; Harry Ischiropoulos
Journal:  Free Radic Biol Med       Date:  2013-07-11       Impact factor: 7.376

4.  Nitrated fibrinogen is a biomarker of oxidative stress in venous thromboembolism.

Authors:  Marissa Martinez; Adam Cuker; Angela Mills; Richard Lightfoot; Yiying Fan; W H Wilson Tang; Stanley L Hazen; Harry Ischiropoulos
Journal:  Free Radic Biol Med       Date:  2012-05-10       Impact factor: 7.376

Review 5.  3-nitrotyrosine modified proteins in atherosclerosis.

Authors:  Leonor Thomson
Journal:  Dis Markers       Date:  2015-03-01       Impact factor: 3.434

6.  Development of an Analytical Assay for Electrochemical Detection and Quantification of Protein-Bound 3-Nitrotyrosine in Biological Samples and Comparison with Classical, Antibody-Based Methods.

Authors:  Ksenija Vujacic-Mirski; Kai Bruns; Sanela Kalinovic; Matthias Oelze; Swenja Kröller-Schön; Sebastian Steven; Milos Mojovic; Bato Korac; Thomas Münzel; Andreas Daiber
Journal:  Antioxidants (Basel)       Date:  2020-05-06

7.  Race and gender variation in response to evoked inflammation.

Authors:  Jane F Ferguson; Parth N Patel; Rhia Y Shah; Claire K Mulvey; Ram Gadi; Prabhjot S Nijjar; Haris M Usman; Nehal N Mehta; Rachana Shah; Stephen R Master; Kathleen J Propert; Muredach P Reilly
Journal:  J Transl Med       Date:  2013-03-12       Impact factor: 5.531

8.  The effect of reagents mimicking oxidative stress on fibrinogen function.

Authors:  Jana Štikarová; Roman Kotlín; Tomáš Riedel; Jiří Suttnar; Kristýna Pimková; Leona Chrastinová; Jan E Dyr
Journal:  ScientificWorldJournal       Date:  2013-10-21

9.  Structural effects of methionine oxidation on isolated subdomains of human fibrin D and αC regions.

Authors:  Patrick R Burney; Nathan White; Jim Pfaendtner
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  Elevated Lactate Levels in Acute Pulmonary Embolism Are Associated with Prothrombotic Fibrin Clot Properties: Contribution of NETs Formation.

Authors:  Michał Ząbczyk; Joanna Natorska; Agnieszka Janion-Sadowska; Krzysztof P Malinowski; Marianna Janion; Anetta Undas
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.